Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Dec;16(12):1890-1897.
doi: 10.2215/CJN.15070920. Epub 2021 Mar 23.

Thinking Outside the Box: Novel Kidney Protective Strategies in Kidney Transplantation

Affiliations
Comment

Thinking Outside the Box: Novel Kidney Protective Strategies in Kidney Transplantation

Hassan N Ibrahim et al. Clin J Am Soc Nephrol. 2021 Dec.

Abstract

Despite the reduction in the incidence of acute rejection, a major risk factor for graft loss, there has been only modest improvement in long-term graft survival. Most cases of kidney graft loss have an identifiable cause that is not idiopathic fibrosis/atrophy or calcineurin inhibitor nephrotoxicity. Distinct immunologic and nonimmunologic factors conspire to lead to a common pathway of allograft fibrosis. It remains plausible that mitigating nonimmunologic damage using strategies proven effective in native kidney disease may yield benefit in kidney transplantation. In this review, we will focus on nonimmunologic aspects of kidney transplant care that may prove to be valuable adjuncts to a well-managed immunosuppression regimen. Topics to be addressed include the roles of hypertension and agents used to treat it, lipid lowering, sodium and water intake, elevated uric acid, metabolic acidosis, and the use of sodium-glucose cotransporter 2 inhibitors on long-term kidney transplant health.

Keywords: hypertension; kidney transplantation; outcomes.

PubMed Disclaimer

Comment on

Similar articles

Cited by

References

    1. Kabani R, Quinn RR, Palmer S, Lewin AM, Yilmaz S, Tibbles LA, Lorenzetti DL, Strippoli GFM, McLaughlin K, Ravani P; Alberta Kidney Disease Network : Risk of death following kidney allograft failure: A systematic review and meta-analysis of cohort studies. Nephrol Dial Transplant 29: 1778–1786, 2014 - PubMed
    1. Lam NN, Boyne DJ, Quinn RR, Austin PC, Hemmelgarn BR, Campbell P, Knoll GA, Tibbles LA, Yilmaz S, Quan H, Ravani P: Mortality and morbidity in kidney transplant recipients with a failing graft: A matched cohort study [published online ahead of print April 14, 2020]. Can J Kidney Health Dis 10.1177/2054358120908677 - DOI - PMC - PubMed
    1. Tong A, Sautenet B, Poggio ED, Lentine KL, Oberbauer R, Mannon R, Murphy B, Padilla B, Chow KM, Marson L, Chadban S, Craig JC, Ju A, Manera KE, Hanson CS, Josephson MA, Knoll G; SONG-Tx Graft Health Workshop Investigators : Establishing a core outcome measure for graft health: A Standardized Outcomes in Nephrology-Kidney Transplantation (SONG-Tx) consensus workshop report. Transplantation 102: 1358–1366, 2018 - PubMed
    1. Merion RM, Goodrich NP, Johnson RJ, McDonald SP, Russ GR, Gillespie BW, Collett D: Kidney transplant graft outcomes in 379 257 recipients on 3 continents. Am J Transplant 18: 1914–1923, 2018 - PubMed
    1. Cheung AK, Rahman M, Reboussin DM, Craven TE, Greene T, Kimmel PL, Cushman WC, Hawfield AT, Johnson KC, Lewis CE, Oparil S, Rocco MV, Sink KM, Whelton PK, Wright JT Jr., Basile J, Beddhu S, Bhatt U, Chang TI, Chertow GM, Chonchol M, Freedman BI, Haley W, Ix JH, Katz LA, Killeen AA, Papademetriou V, Ricardo AC, Servilla K, Wall B, Wolfgram D, Yee J; SPRINT Research Group : Effects of intensive BP control in CKD. J Am Soc Nephrol 28: 2812–2823, 2017 - PMC - PubMed